Climb Bio Income Statement (2020-2026) | CLYM

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
15.59M12.26M26.24M26.33M26.35M26.39M26.82M26.88M27.37M27.63M27.66M30.35M67.22M48.16M67.58M67.76M68.18M67.81M68.21M76.15M
Operating items
Research & Development (Quarter)
5.99M6.88M8.26M8.77M4.26M4.93M5.72M3.69M2.88M3.13M1.09M1.05M6.24M5.96M17.33M6.58M9.07M13.74M9.37M9.71M
Selling, General & Administrative (Quarter)
3.39M3.82M4.87M4.93M4.49M4.63M17.72M3.03M2.12M2.00M1.91M3.67M5.49M4.95M5.69M4.10M5.82M5.56M5.84M5.64M
Other Operating Expenses (Quarter)
0.02M0.06M0.09M0.90M1.11M1.26M1.49M2.79M
Operating Expenses (Quarter)
9.38M10.70M13.13M13.70M8.75M9.55M23.44M6.71M5.00M5.12M3.00M56.37M11.73M10.91M23.02M10.68M14.89M19.30M15.21M15.36M
Operating Income (Quarter)
-9.38M-10.70M-13.13M-13.70M-8.75M-9.55M-23.44M-6.71M-5.00M-5.12M-3.00M-56.37M-11.73M-10.91M-23.02M-10.68M-14.89M-19.30M-15.21M-15.36M
EBIT (Quarter)
-9.38M-10.70M-13.13M-13.70M-8.75M-9.55M-23.44M-6.71M-5.00M-5.12M-3.00M-56.37M-11.73M-10.91M-23.02M-10.68M-14.89M-19.30M-15.21M-15.36M
Non-operating items
Non Operating Investment Income (Quarter)
0.02M-0.10M-0.40M-0.08M0.02M0.22M0.26M0.06M0.02M0.01M0.00M0.20M-0.18M0.26M0.03M0.15M-0.03M-0.28M-0.22M
Interest & Investment Income (Quarter)
0.15M0.38M0.76M0.90M1.11M1.26M1.35M1.34M1.49M2.79M2.52M2.29M2.17M2.04M1.83M1.51M1.85M
Other Non Operating Income (Quarter)
-0.23M0.16M-0.16M-0.90M-0.93M1.79M1.15M1.49M1.03M1.48M1.31M-0.00M0.05M-0.03M-0.05M-0.16M-0.03M-0.05M-0.03M0.01M
Non Operating Income (Quarter)
1.48M2.84M2.24M2.01M2.00M1.49M1.86M
Net income details
EBT (Quarter)
-51.11M-21.40M-29.11M-17.49M-12.65M-14.49M-24.98M-7.84M-5.06M-24.63M-2.74M-57.67M-9.88M-8.64M-21.27M-8.54M-14.46M-29.20M-46.05M-92.40M
Profit After Tax (Quarter)
-9.62M-10.67M-13.60M-14.60M-9.68M-7.54M-22.29M-5.22M-3.97M-3.63M-1.70M-54.89M-8.69M-8.62M-20.78M-8.67M-12.89M-17.52M-14.00M-13.72M
Income from Non-Controlling Interests (Quarter)
-9.63M-10.65M-13.60M
Income from Continuing Operations (Quarter)
-51.11M-21.40M-29.11M-17.49M-12.65M-14.49M-24.98M-7.84M-5.06M-24.63M-2.74M-57.67M-9.88M-8.64M-21.27M-8.54M-14.46M-29.20M-46.05M-92.40M
Consolidated Net Income (Quarter)
-51.11M-21.40M-29.11M-17.49M-12.65M-14.49M-24.98M-7.84M-5.06M-24.63M-2.74M-57.67M-9.88M-8.64M-21.27M-8.54M-14.46M-29.20M-46.05M-92.40M
Income towards Parent Company (Quarter)
-51.11M-21.40M-29.11M-17.49M-12.65M-14.49M-24.98M-7.84M-5.06M-24.63M-2.74M-57.67M-9.88M-8.64M-21.27M-8.54M-14.46M-29.20M-46.05M-92.40M
Preferred Dividend Payments (Quarter)
1.32M
Net Income towards Common Stockholders (Quarter)
-10.94M-10.54M-13.20M-14.60M-9.68M-7.76M-24.98M-7.84M-5.06M-24.63M-2.74M-57.67M-9.88M-8.64M-21.27M-8.54M-14.46M-29.20M-46.05M-92.40M
Additional items
EPS (Basic) (Quarter)
-0.70-0.86-0.50-0.56-0.37-0.30-0.94-0.29-0.19-0.91-0.10-1.90-0.15-0.18-0.32-0.13-0.21-0.43-0.68-1.21
EPS (Diluted) (Quarter)
-0.70-0.86-0.50-0.56-0.37-0.30-0.94-0.29-0.19-0.91-0.10-1.90-0.15-0.18-0.32-0.13-0.21-0.43-0.68-1.21
Shares Outstanding (Quarter)
15.59M12.26M26.24M26.30M26.34M26.31M26.49M26.84M27.07M26.99M27.64M30.35M67.01M48.16M67.46M67.59M68.00M67.81M68.21M76.15M
Shares Outstanding (Diluted) (Quarter)
15.59M12.26M26.24M26.30M26.34M26.31M26.49M26.84M27.07M26.99M27.64M30.35M67.01M48.16M67.46M67.59M68.00M67.81M68.21M76.15M
EBITDA (Quarter)
-9.38M-10.70M-13.13M-13.70M-8.75M-9.55M-23.44M-6.71M-5.00M-5.12M-3.00M-56.37M-11.73M-10.91M-23.02M-10.68M-14.89M-19.30M-15.21M-15.36M
Interest Expenses (Quarter)
41.73M10.70M15.97M3.94M4.29M5.70M2.44M2.23M1.32M20.86M1.07M2.79M0.94M0.25M0.53M0.04M1.61M11.73M32.36M78.90M